Speaker Profile

M.D., President, Mayo Clinic Platform

Biography
Dr. John D. Halamka, M.D., M.S., is an American business executive and physician. He is president of the Mayo Clinic Platform, a group of digital and long-distance health care initiatives. Trained in emergency medicine and medical informatics, Halamka has been developing and implementing health care information strategy and policy for more than 25 years. He specializes in artificial intelligence, the adoption of electronic health records and the secure sharing of healthcare data for care coordination, population health, and quality improvement. In 2020, Halamka was elected to the National Academy of Medicine (NAM). Prior to his appointment at Mayo Clinic, he was chief information officer at Beth Israel Deaconess Medical Center. He is a practicing emergency medicine physician. As the International Healthcare Innovation Professor at Harvard Medical School, Halamka helped the George W. Bush administration, the Obama administration and governments around the world plan their health care information strategies.

Talk
The Breadth and Depth of Trustless Data Sharing Technology
This session brings together two sides of the data sharing innovation landscape – technologists and traditional healthcare systems. The group will discuss the breadth and depth of the impact data sharing technologies will have for insurers, digital health companies, and traditional healthcare systems seeking to innovate and push precision medicine forward.


 Session Abstract – PMWC 2022 Silicon Valley


The COVID-19 pandemic is driving the unprecedented transformation of the global medical research ecosystem through the search for effective new therapeutics that can help ease symptoms and prevent death among COVID-19 patients.

  • SARS_CoV-2 Outbreak Surveillance (PANEL)
    Session Chair: Charles Chiu, UCSF
    - Bronwyn MacInnis, The Broad Institute - Duncan MacCannell, CDC
    - Ephraim Tsalik, Duke University
    - Joel Sevinsky, Theiagen
  • Experiences from the Front Lines of a National Viral Surveillance Organization
    Session Chair: James Lu, Helix
    - Rick Bright, Rockefeller Foundation
  • COVID-19 Testing: Who, When, What? The Challenges of Testing During the Pandemic
    Session Chair: Alan Wu, UCSF
    - Gary Pestano, Biodesix
    - John Barnes, CDC
    - Kathleen Jacobson, CA COVID Testing Task Force
  • Updates in COVID-19 Drug Development
    - Mark Dresser, Gilead Sciences
    - John Fahy, UCSF
    - Yi Shi, University of Pittsburgh
    - Wendy Yeh, Vir Biotechnology
  • Accelerating COVID-19 Therapeutic Interventions
    - Stacey Adams, FNIH
  • Past, Present, and Future: How will We Manage the Next Pandemic?
    Session Chair: Julianne McCall, California Initiative to Advance Precision Medicine
    - Lawrence Corey, Fred Hutchinson Cancer Research Center
    - Yvonne A Maldonado, Stanford
    - Robert Wachter, UCSF
    - Tomas Aragon, CDPH